GSK PLC header image

GSK PLC

GSK

Equity

ISIN null / Valor 120042705

New York Stock Exchange, Inc (2026-06-05)
USD 51.52+0.49%

GSK PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

GSK PLC is a global healthcare company specializing in pharmaceuticals and vaccines, dedicated to preventing and treating a wide range of diseases. The company operates through key therapeutic areas including respiratory, immunology and inflammation, oncology, as well as HIV and other infectious diseases. Notably, GSK majority-owns ViiV Healthcare, the sole company exclusively focused on HIV treatment and prevention, aiming to end the HIV epidemic. With a robust portfolio of over 20 marketed vaccines, GSK delivers more than one million vaccine doses daily, addressing infectious diseases across all age groups. The company's approach emphasizes early intervention and the use of advanced technologies to support healthcare systems and improve patient outcomes. GSK's commitment to responsible business practices underpins its strategy for long-term growth and trust-building with stakeholders.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

25.2%1Y
50.3%3Y
5.95%5Y

Performance

26.9%1Y
63.9%3Y
51.8%5Y

Volatility

Market cap

103555 M

Market cap (USD)

Daily traded volume (Shares)

4,048,091

Daily traded volume (Shares)

1 day high/low

34.04 / 33.56

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

H. Lundbeck A/S
H. Lundbeck A/S H. Lundbeck A/S Valor: 119252584
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.21%DKK 37.50
Legend Biotech Corporation
Legend Biotech Corporation Legend Biotech Corporation Valor: 54834759
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.62%USD 32.62
AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited AstraZeneca Pharma India Limited Valor: 2593348
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.20%INR 8,598.60
Teva Pharmaceutical Industries Ltd
Teva Pharmaceutical Industries Ltd Teva Pharmaceutical Industries Ltd Valor: 758744
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.70%USD 34.19
PTC Therapeutics Inc
PTC Therapeutics Inc PTC Therapeutics Inc Valor: 2515234
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.47%USD 70.97
IPCA Laboratories Limited
IPCA Laboratories Limited IPCA Laboratories Limited Valor: 115718957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.43%INR 1,643.05
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited Alembic Pharmaceuticals Limited Valor: 11500585
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.17%INR 736.95
Becton Dickinson & Co.
Becton Dickinson & Co. Becton Dickinson & Co. Valor: 912061
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.07%USD 151.16
Ste Virbac SA
Ste Virbac SA Ste Virbac SA Valor: 524407
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.28%EUR 350.00
Surgery Partners Inc
Surgery Partners Inc Surgery Partners Inc Valor: 29308003
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.22%USD 13.71